Men with Kennedy disease have a reduced risk of androgenetic alopecia

British Journal of Dermatology

Volumn 157, Issue 2, 2007, Pages 290-294

  Sinclair, R ^a   Greenland, K J ^a   Van Egmond, S ^a   Hoedemaker, C ^a   Chapman, A ^a   Zajac, J D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Androgen receptor gene; Androgenetic alopecia; CAG repeat; Kennedy disease; Spinal and bulbar muscular atrophy

Indexed keywords

ANDROGEN RECEPTOR; POLYGLUTAMINE;

ADULT; AGE; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FUNCTION; HEALTH SURVEY; HUMAN; KENNEDY DISEASE; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; ONLINE SYSTEM; PREVALENCE; PRIORITY JOURNAL; RISK; SCORING SYSTEM;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALOPECIA; GYNECOMASTIA; HUMANS; MALE; MIDDLE AGED; MUSCULAR ATROPHY, SPINAL; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TRINUCLEOTIDE REPEAT EXPANSION; VICTORIA;

EID: 34447550504     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08026.x     Document Type: Article

References (25)

1. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 1968 18 : 671 80.
2. Zajac JD, MacLean HE. Kennedy's disease: clinical aspects. In : Genetic Instabilities, Hereditary Neurological Diseases (Wells RD, Warren ST, eds). San Diego : Academic Press, 1998 87 100.
3. Greenland KJ, Zajac JD. Kennedy's disease: pathogenesis and clinical approaches. Intern Med J 2004 34 : 279 86.
4. Sperfeld AD, Karitzky J, Brummer D et al. X-linked bulbospinal neuronopathy. Arch Neurol 2002 59 : 1921 6.
5. La Spada AR, Wilson EM, Lubahn DB et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991 352 : 77 9.
6. Amato AA, Prior TW, Barohn RJ et al. Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology 1993 43 : 791 4.
7. Lieberman AP, Harmison G, Strand AD et al. Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum Mol Genet 2002 11 : 1967 76.
8. Tanaka F, Doyu M, Ito Y et al. Founder effect in spinal and bulbar muscular atrophy (SBMA). Hum Mol Genet 1996 5 : 1253 7.
9. Udd B, Juvonen V, Hakamies L et al. High prevalence of Kennedy's disease in Western Finland - is the syndrome underdiagnosed? Acta Neurol Scand 1998 98 : 128 33.
10. Sinclair R. Male pattern androgenetic alopecia. Br Med J 1998 317 : 865 9.
11. Nyholt DR, Gillespie NA, Heath AC, Martin NG. Genetic basis of male pattern baldness. J Invest Dermatol 2003 121 : 1561 4.
12. Inui S, Fukuzato Y, Nakajima T et al. Identification of androgen-inducible TGF-β1 derived from dermal papilla cells as key mediator in androgenetic alopecia. J Investig Dermatol Symp Proc 2003 8 : 69 71.
13. Inaba M, McKinstry CT, Ezaki T. The process of replacement of vellus hairs by coarse hairs. J Dermatol Surg Oncol 1981 7 : 732 6.
14. Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med 2002 2002 : 1 11.
15. Severi G, Sinclair R, Hopper JL et al. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol 2003 149 : 1207 13.
16. Gan DCC, Sinclair R. Prevalence of male and female pattern hair loss in Maryborough. J Invest Dermatol Symp Proc 2005 10 : 184 9.
17. Ellis JA, Stebbing M, Harrap SB. Genetic analysis of the male pattern baldness and the 5alpha-reductase genes. J Invest Dermatol 1998 110 : 849 53.
18. Ellis JA, Stebbing M, Harrap SB. Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol 2001 116 : 452 5.
19. Hayes VM, Severi G, Eggleton SA et al. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev 2005 14 : 993 6.
20. Hillmer AM, Hanneken S, Ritzmann S et al. Genetic variation in the human androgen receptor gene is the major determinant of early-onset androgenetic alopecia. Am J Hum Genet 2005 77 : 140 8.
21. MacLean HE, Choi WT, Rekaris G et al. Abnormal androgen receptor binding affinity in subjects with Kennedy's disease (spinal and bulbar muscular atrophy). J Clin Endocrinol Metab 1995 80 : 508 16.
22. Mhatre AN, Trifiro MA, Kaufman M et al. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat Genet 1993 5 : 184 8.
23. Wakisaka N, Taira Y, Ishikawa M et al. Effectiveness of finasteride on patients with male pattern baldness who have different androgen receptor gene polymorphism. J Investig Dermatol Symp Proc 2005 10 : 293 4.
24. Ferriman DM, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961 21 : 1440 7.
25. Norwood O. Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 2001 27 : 53 4.